Literature DB >> 30964331

Quinoxaline-1,4-dioxide derivatives inhibitory action in melanoma and brain tumor cells.

Liliana Silva1,2, Pedro Coelho2,3,4,5, Raquel Soares4,5, Cristina Prudêncio2,3,5, Mónica Vieira2,3,5.   

Abstract

Aim: Quinoxaline-1,4-dioxide derivatives are synthetic heterocyclic compounds with multiple biological and pharmacological effects. In this study, we investigated the bioactivity of five quinoxaline-1,4-di-N-oxides derivatives in different animal cell lines. Materials & methods: Using in vitro cell cultures, we evaluated the influence of quinoxaline-1,4-dioxide, 2-methylquinoxaline-1,4-dioxide, 2-amino-3-cyanoquinoxaline-1,4-dioxide, 3-methyl-2-quinoxalinecarboxamide-1,4-dioxide and 2-hydroxyphenazine-N,N-dioxide (2HF) in the viability, migration and proliferation of nonmalignant (3T3-L1 and human dermal microvascular endothelial cell) and malignant (B16-F10, MeWo, GL-261 and BC3H1) cell lines.
Results: The viability IC50 concentrations for each quinoxaline-1,4-di-N-oxide derivative were calculated, and a concomitant reduction of migration and proliferation was observed mainly in malignant cell lines.
Conclusion: 2HF exhibited potent anti-viability, anti-migration and anti-proliferative actions selectively in tumor cells, nevertheless more studies are required to further investigate 2HF promising biologic effects.

Entities:  

Keywords:  1,4-benzodiazine derivatives; anticancer; bioactivity; brain tumor; melanoma

Mesh:

Substances:

Year:  2019        PMID: 30964331     DOI: 10.4155/fmc-2018-0251

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  1 in total

Review 1.  Potential targets and treatments affect oxidative stress in gliomas: An overview of molecular mechanisms.

Authors:  Shiyu Liu; Lihua Dong; Weiyan Shi; Zhuangzhuang Zheng; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.